KAL suppressed the expression of PPARγ in liver tissues, and Serpina4-/- significantly improved the downregulation of PPARγ in MCD-induced NAFLD rats (Fig. 6b, supplementary Fig. 5b). Here, SERPINA4 is linked to metabolic dysfunction-associated steatotic liver disease.